IP Library › Granted Patent US 11,421,022
Granted Patent B2
US 11,421,022 · App. 14/579,192 · Granted Aug 23, 2022

Method for making antibody Fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof

Inventors: Sebastian Fenn (Munich, DE); Erhard Kopetzki (Penzberg, DE)
Assignee: HOFFMANN-LA ROCHE INC.
C07K16/18A61K47/6889C07K16/00C07K16/32C12N9/52C12N15/62C12Y304/2207C07K2317/52C07K2317/55C07K2319/00C07K2319/50C07K2319/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,421,022
App. No.
14/579,192
Granted
Aug 23, 2022
Kind
B2
Abstract

Herein is reported a method for producing an antibody Fc-region conjugate comprising as first component an antibody Fc-region and as second component at least one binding entity that specifically binds to a target using a transpeptidase for enzymatic conjugation of the antibody Fc-region to at least one binding entity.

Claims (8)

1. A method for producing an antibody Fc-region conjugate, which comprises as a first component an antibody Fc-region and as a second component a Fab that specifically binds to a target, wherein the method comprises incubating:

(i) a Fab fragment comprising the amino acid sequence KSCGSLPETGGSGSHHHHHH (SEQ ID NO: 76) within its 20 C-terminal amino acid residues, and an antibody Fc-region, comprising two heavy chain fragments each comprising an N-terminus, which comprises at one of its N-termini the amino acid sequence GGCPPC (SEQ ID NO: 17), with the enzyme Sortase A; or

(ii) a Fab fragment comprising the amino acid sequence KSCGGGSLPETGGSGSHHHHHH (SEQ ID NO: 75), and an antibody Fc-region, comprising two heavy chain fragments each comprising an N-terminus, which comprises at one of its N-termini the amino acid sequence GGCPPC (SEQ ID NO: 17), with the enzyme Sortase A,

thereby producing the antibody Fc-region conjugate.

2. The method of claim 1 , further comprising, prior to incubating the antibody Fc-region and the Fab fragment:

(a) culturing a first host cell comprising a nucleic acid encoding the antibody Fc-region component of the conjugate under conditions suitable for expression of the antibody Fc-region; and

(b) culturing a second host cell comprising a nucleic acid encoding the Fab fragment under conditions suitable for expression of the Fab fragment.

3. The method of claim 1 , wherein the Fc-region comprises, at both N-termini, the amino acid sequence GGCPPC (SEQ ID NO: 17).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2015
From: FENN, SEBASTIAN; KOPETZKI, ERHARD
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 034890/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2015
From: ROCHE DIAGNOSTICS GMBH
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 034890/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2015
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 034890/0889 →
Priority Claims (1)
EP 12173876 · Jun 27, 2012 · regional
Continuity (2)
Continuation PCTEP2013063259 · Jun 25, 2013
Related Publication 20150232541A1 · Aug 20, 2015
Cited By (2)
US 12,383,631 US 12,698,332